Tissue distribution of human AKR1C3 and rat homolog in the adult genitourinary system

Journal of Histochemistry and Cytochemistry

Volumn 56, Issue 9, 2008, Pages 853-861

  Azzarello, Joseph ^a   Fung, Kar Ming ^a,b   Lin, Hsueh Kung ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aldo keto reductase; Bladder; Hydroxysteroid dehydrogenase; Kidney; Prostate; Testis

Indexed keywords

3ALPHA HYDROXYSTEROID DEHYDROGENASE; ALDO KETO REDUCTASE ENZYME; MONOCLONAL ANTIBODY; TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; BLADDER; CROSS REACTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROTEIN ANALYSIS; RAT; TESTIS; TISSUE DISTRIBUTION; UROGENITAL SYSTEM;

17-HYDROXYSTEROID DEHYDROGENASES; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE (B-SPECIFIC); 3-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; ANTIBODIES, MONOCLONAL; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; IMMUNOHISTOCHEMISTRY; MALE; MULTIENZYME COMPLEXES; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY; UROGENITAL SYSTEM;

ANIMALIA; MURINAE; RATTUS; RODENTIA;

EID: 49749125298     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2008.951384     Document Type: Article

References (42)

1. Azadzoi KM, Heim VK, Tarcan T, Siroky MB (2004) Alteration of urothelial-mediated tone in the ischemic bladder: role of eicosanoids. Neurourol Urodyn 23:258-264
2. Barbier O, Lapointe H, El Alfy M, Hum DW, Belanger A (2000) Cellular localization of uridine diphosphoglucuronosyltransferase 2B enzymes in the human prostate by in situ hybridization and immunohistochemistry. J Clin Endocrinol Metab 85:4819-4826
3. Campean V, Theilig F, Paliege A, Breyer M, Bachmann S (2003) Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse). Am J Physiol Renal Physiol 285:F19-32
4. de Jongh R, van Koeveringe GA, van Kerrebroeck PE, Markerink-van Ittersum M, de Vente J, Gillespie JI (2007) The effects of exogenous prostaglandins and the identification of constitutive cyclooxygenase I and II immunoreactivity in the normal guinea pig bladder. BJU Int 100:419-429
5. Desmond JC, Mountford JC, Drayson MT, Walker EA, Hewison M, Ride JP, Luong QT, et al. (2003) The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Cancer Res 63:505-512
6. Deyashiki Y, Ogasawara A, Nakayama T, Nakanishi M, Miyabe Y, Sato K, Hara A (1994) Molecular cloning of two human liver 3α-hydroxysteroid/ dihydrodiol dehydrogenase isoenzymes that are identical with chlordecone reductase and bile-acid binder. Biochem J 299:545-552
7. Dufort I, Rheault P, Huang XF, Soucy P, Luu-The V (1999) Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase. Endocrinology 140:568-574
8. Dufort I, Soucy P, Labrie F, Luu-The V (1996) Molecular cloning of human type 3 3α-hydroxysteroid dehydrogenase that differs from 20α-hydroxysteroid dehydrogenase by seven amino acids. Biochem Biophys Res Commun 228:474-479
9. Fung KM, Samara ENS, Wong C, Metwalli A, Krlin R, Bane B, Liu CZ, et al. (2006) Increased expression of type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma. Endocr Relat Cancer 13:169-180
10. Glodny B, Pauli GF (2006) The vasodepressor function of the kidney: prostaglandin E2 is not the principal vasodepressor lipid of the renal medulla. Acta Physiol (Oxf) 187:419-430
11. Hara A, Matsuura K, Tamada Y, Sato K, Miyabe Y, Deyashiki Y, Ishida N (1996) Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells. Biochem J 313:373-376
12. Hebert RL, Jacobson HR, Breyer MD (1991) Prostaglandin E2 inhibits sodium transport in rabbit cortical collecting duct by increasing intracellular calcium. J Clin Invest 87:1992-1998
13. Hyndman D, Bauman DR, Heredia VV, Penning TM (2003) The aldo-keto reductase superfamily homepage. Chem Biol Interact 143-144:621-631
14. Jez JM, Bennett MJ, Schlegel BP, Lewis M, Penning TM (1997a) Comparative anatomy of the aldo-keto reductase superfamily. Biochem J 326:625-636
15. Jez JM, Flynn TG, Penning TM (1997b) A new nomenclature for the aldo-keto reductase superfamily. Biochem Pharmacol 54:639-647
16. Khanna M, Qin KN, Wang RW, Cheng KC (1995) Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3α-hydroxysteroid dehydrogenases. J Biol Chem 270:20162-20168
17. Krasnopolsky L, Levin RM, Longhurst PA (1995) The role of the mucosa in the in vitro changes in guinea pig bladder function which occur after sensitization with ovalbumin. Pharmacology 50:119-127
18. Lan Q, Mumford JL, Shen M, Demarini DM, Bonner MR, He X, Yeager M, et al. (2004) Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis 25:2177-2181
19. Leihy MW, Shaw G, Wilson JD, Renfree MB (2004) Penile development is initiated in the tammar wallaby pouch young during the period when 5alpha-androstane-3alpha,17beta-diol is secreted by the testes. Endocrinology 145:3346-3352
20. Lewis MJ, Wiebe JP, Heathcote JG (2004) Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma. BMC Cancer 4:27
21. Lin HK, Jez JM, Schlegel BP, Peehl DM, Pachter JA, Penning TM (1997) Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution. Mol Endocrinol 11:1971-1984
22. Lin HK, Steckelbroeck S, Fung KM, Jones AN, Penning TM (2004) Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate. Steroids 69:795-801
23. Mahadevan D, DiMento J, Croce KD, Riley C, George B, Fuchs D, Mathews T, et al. (2006) Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia. Am J Hematol 81:779-786
24. Matsuura K, Shiraishi H, Hara A, Sato K, Deyashiki Y, Ninomiya M, Sakai S (1998) Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity. J Biochem 124:940-946
25. Matzdorf C, Kurtz A, Hocherl K (2007) COX-2 activity determines the level of renin expression but is dispensable for acute upregulation of renin expression in rat kidneys. Am J Physiol Renal Physiol 292:F1782-1790
26. Nakamura Y, Suzuki T, Nakabayashi M, Endoh M, Sakamoto K, Mikami Y, Moriya T, et al. (2005) In situ androgen producing enzymes in human prostate cancer. Endocr Relat Cancer 12:101-107
27. Oleksiewicz MB, Thorup I, Nielsen HS, Andersen HV, Hegelund AC, Iversen L, Guldberg TS, et al. (2005) Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo. Toxicol Pathol 33:552-560
28. Pawlowski JE, Huizinga M, Penning TM (1991) Cloning and sequencing of the cDNA for rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase. J Biol Chem 266:8820-8825
29. Pawlowski JE, Penning TM (1994) Overexpression and mutagenesis of the cDNA for rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase. Role of cysteines and tyrosines in catalysis. J Biol Chem 269:13502-13510
30. Penning TM (2003) Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action. Hum Reprod Update 9:193-205
31. Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, et al. (2000) Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 351:67-77
32. Penning TM, Mukharji I, Barrows S, Talalay P (1984) Purification and properties of a 3α-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs. Biochem J 222:601-611
33. Penning TM, Sharp RB (1987) Prostaglandin dehydrogenase activity of purified rat liver 3α-hydroxysteroid dehydrogenase. Biochem Biophys Res Commun 148:646-652
34. Penning TM, Steckelbroeck S, Bauman DR, Miller MW, Jin Y, Peehl DM, Fung KM, et al. (2006) Aldo-keto reductase (AKR) 1C3: Role in prostate disease and the development of specific inhibitors. Mol Cell Endocrinol 248:182-191
35. Qi Z, Cai H, Morrow JD, Breyer MD (2006) Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta. Hypertension 48:323-328
36. Rakoff-Nahoum S, Medzhitov R (2007) Prostaglandin-secreting cells: a portable first aid kit for tissue repair. J Clin Invest 117:83-86
37. Rizner TL, Smuc T, Rupreht R, Sinkovec J, Penning TM (2006) AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer. Mol Cell Endocrinol 248: 126-135
38. Schroder A, Newgreen D, Andersson KE (2004) Detrusor responses to prostaglandin E2 and bladder outlet obstruction in wild-type and Ep1 receptor knockout mice. J Urol 172:1166-1170
39. Stanbrough M, Bubley G, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG, et al. (2006) Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 66:2815-2825
40. Stichtenoth DO, Marhauer V, Tsikas D, Gutzki FM, Frolich JC (2005) Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers. Kidney Int 68:2197-2207
41. Vitzthum H, Abt I, Einhellig S, Kurtz A (2002) Gene expression of prostanoid forming enzymes along the rat nephron. Kidney Int 62:1570-1581
42. Wako K, Kawasaki T, Yamana K, Suzuki K, Jiang S, Umezu H, Nishiyama T, et al. (2008) Expression of androgen receptor through androgen-converting enzymes is associated with biological aggressiveness in prostate cancer. J Clin Pathol 61:448-454